Welgene Biotech
Welgene Biotech is a privately held, small (11-50 employee) biotechnology company founded in 2003 and based in Taipei; the available data does not specify its products, technology, or customer base.
- Company typePrivate
- Founded2003
- HeadquartersTaipei, China
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Welgene Biotech does
Welgene Biotech is a privately held, for-profit biotechnology company founded in 2003 and headquartered in Taipei. The company operates with a small workforce in the 11-50 employee range and remains private with no disclosed public listing, parent company, or subsidiaries. Beyond its classification as a biotechnology firm, the available input data provides no substantive detail on its specific product lines, underlying platform technology, therapeutic or research focus, or proprietary capabilities.
The input does not disclose the company's business model, revenue mechanics, pricing structure, go-to-market motion, or customer segments. The primary web source consisted only of a website verification/loading page, which yielded no product, technology, customer, or corporate governance information. A financial table included in the input reports revenue and profitability figures in the trillions of dollars, which are internally implausible for a company of this size and headcount and are treated as unreliable rather than as evidence of actual scale.
In summary, the evidence supports only a high-level firmographic profile: a long-established (founded 2003), small, private Taipei-based biotechnology company. All deeper analytical dimensions — products, technology, moats, customers, and financials — are unsupported by the supplied data and should be treated as significant information gaps.
Welgene Biotech firmographics
Firmographics- Name
- Welgene Biotech
- Website
- https://welgene.com.tw
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Welgene Biotech is a privately held, small (11-50 employee) biotechnology company founded in 2003 and based in Taipei; the available data does not specify its products, technology, or customer base.
- Ownership category
- akta.pro rank
Welgene Biotech industry classification
Industry- Product category
- Biotechnology
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Small-Molecule API Process Development & Route Scouting (HLAGAHAA)
Keywords
Where Welgene Biotech is headquartered
LocationHeadquarters
- HQ city
- Taipei
- HQ country
- China
- HQ region
- Asia
Markets served
Welgene Biotech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D
Welgene Biotech product offering
Product offeringCore offering
Welgene Biotech operates as a biotechnology company. Based on the limited source material available, the company's website (welgene.com.tw) presented only a verification/loading page with no substantive product, service, or capability details exposed. The firmographic descriptor identifies Welgene Biotech as a biotechnology company headquartered in Taipei, founded in 2003, with 11-50 employees.
Differentiator
Problem solved
Functional benefit
Companies that use Welgene Biotech
Customer profileIdeal customer profiles1 record
Welgene Biotech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Welgene Biotech competitors and assessment
Company assessmentDirect peers
- FUJIFILM Irvine Scientific: FUJIFILM Irvine Scientific is a global leader in cell culture media and bioprocessing products for the biopharmaceutical industry. It is the most direct comparable to a Taiwan-based cell culture media and life science tools company of Welgene's likely profile.
- Corning Life Sciences: Corning Life Sciences manufactures cell culture vessels, media, and related consumables for research and bioprocessing. Its product portfolio overlaps directly with the cell culture and life science tools focus typical of a small Taiwan-based biotech tools firm.
Broad incumbents
- Thermo Fisher Scientific (Gibco brand): Thermo Fisher's Gibco brand is the dominant global supplier of cell culture media, sera, and reagents. It serves the same biopharma and research customer base as a small media and cell culture tools provider like Welgene.
- Lonza Group: Lonza is a major global CDMO and supplier of cell culture media, cell lines, and bioprocessing services. It overlaps with Welgene's likely offerings across cell line development and media, while operating at vastly greater scale.
- Cytiva: Cytiva (formerly GE Healthcare Life Sciences) supplies bioprocessing equipment, cell culture media, and services for the biopharmaceutical industry. It competes in many of the same life science tools categories that a media-focused Taiwan firm would address.
- Merck KGaA (Life Science / MilliporeSigma): MilliporeSigma supplies bioprocessing tools, cell culture media, and lab consumables used in pharmaceutical and biotech manufacturing. It competes broadly with small life science tools providers in upstream bioprocessing inputs.
- Sartorius: Sartorius provides bioprocessing equipment, consumables, and services for the biopharmaceutical industry, including cell culture-related products. It serves the same bioproduction customers that a media and cell line tools company would target.
Emerging players
- GenScript: GenScript is a global biotech company offering gene synthesis, peptide synthesis, and cell line development services. Its cell line engineering and biology services overlap with the type of upstream bioprocessing services a small Asian life science tools firm would offer.
- Bio-Techne: Bio-Techne provides reagents, proteins, and cell culture products for life science research and bioprocessing. Its product categories in cell culture and biotech reagents overlap directly with those of a cell culture and life science tools provider.
Regional players
- Bioneer: Bioneer is a Korean biotech company specializing in molecular biology tools, cell culture media, and life science research products. As an APAC-based life science tools provider, it is a strong regional comparable to a Taipei-headquartered firm of similar size and scope.
Market position
Strengths3 records
Weaknesses3 records
Key risks4 records
Key highlights3 records
Customer concentration
Welgene Biotech social profiles
Digital presenceWelgene Biotech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Welgene Biotech leadership team
Management profileNumber of profiles
Welgene Biotech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Welgene Biotech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Welgene Biotech
What does Welgene Biotech do?
Welgene Biotech operates as a biotechnology company. Based on the limited source material available, the company's website (welgene.com.tw) presented only a verification/loading page with no substantive product, service, or capability details exposed. The firmographic descriptor identifies Welgene Biotech as a biotechnology company headquartered in Taipei, founded in 2003, with 11-50 employees.
Is Welgene Biotech a public or private company?
Welgene Biotech is a private company. It is classified as unknown and is currently operating.
When was Welgene Biotech founded?
Welgene Biotech was founded in 2003. It employs 11 to 50 people.
Where is Welgene Biotech based?
Welgene Biotech is headquartered in Taipei, China, in the Asia region.
Who are Welgene Biotech's main competitors?
Direct peers on record are FUJIFILM Irvine Scientific and Corning Life Sciences. Broad incumbents are Thermo Fisher Scientific (Gibco brand), Lonza Group, Cytiva, Merck KGaA (Life Science / MilliporeSigma) and Sartorius. Emerging players are GenScript and Bio-Techne. Bioneer is listed as a regional player.
Does Welgene Biotech have an API?
No public API is recorded for Welgene Biotech.
What industry is Welgene Biotech in?
Welgene Biotech's product category is Biotechnology. Its primary akta.pro industry code is HLAGAHAA, Small-Molecule API Process Development & Route Scouting. Its NAICS code is 541714 and its SIC code is 8731.